Advertisement
Home Tags Heart / Stroke-Related: High Cholesterol

Tag: Heart / Stroke-Related: High Cholesterol

Many patients report lack of confidence or knowledge in keeping cholesterol under control

AHA: Patients Lack Confidence in Managing Their Cholesterol

0
Patients feel least informed about target body weight, types of cholesterol, goals for management
Evolocumab and inclisiran

ACC: Meds Targeting PCSK9 Show Benefit for High-Risk Patients

0
Evolocumab and inclisiran inhibit proprotein convertase subtilisin-kexin type 9
For patients undergoing arthroscopic rotator cuff repair

AAOS: Cholesterol, LDL Impact Rotator Cuff Repair Revision

0
Statins mitigate this effect, with revision rates not significantly different for patients prescribed statins
Cholesterol's impact on myocardial infarction may differ by age

ACC: Younger MI Patients More Likely to Have Low HDL, High LDL

0
Different measures may be required to accurately identify MI risk in this age group
For women with early-stage

Cholesterol Lowering Rx Cuts Recurrence in Breast Cancer

0
Initiation of CLM during endocrine tx tied to improved disease-free survival, recurrence-free intervals
For youth with type 1 diabetes

HbA1c, Waist-to-Height Ratio Predict Dyslipidemia in T1DM

0
For youth with type 1 diabetes, hemoglobin A1c and waist-to-height ratio are modifiable risk factors
The cholesterol-lowering supplement red yeast rice could pose the same health risks to users as statin drugs

Safety Profile of Red Yeast Rice Found Similar to Statins

0
The supplements linked to myalgias, other adverse effects similar to statins
The health and economic impact of three cardiovascular disease preventive services varies with demographic characteristics and clinical objectives

Health, Economic Impact of CVD Preventive Services Varies

0
Highest health impact for hypertension screening and treatment, lowest for aspirin counseling
Achieving targets of low-density lipoprotein (LDL)

Achieving LDL-Particle Targets Deemed Cost-Effective

0
LDL-lowering therapy guided by LDL-P is cost-effective, with greater economic benefits over time
Variants in genes encoding proprotein convertase subtilisin-kexin type 9 and 3-hydroxy-3-methylglutarylcoenzyme A reductase are associated with almost equivalent effects on the risk of cardiovascular events and diabetes per unit decrease in low-density lipoprotein cholesterol level

Similar Effects for PCSK9, HMGCR Variant-Mediated Lower LDL

0
Almost equivalent effects on cardiovascular events, diabetes per unit decrease in LDL-cholesterol level